Jun 3 2015
Essential Medical, Inc., a privately held medical device company, announced today that it has been invited to speak at the 2015 Jefferies Global Healthcare Conference in New York city on June 4th.
The company will present on its MANTA Large Bore closure system, including a review of first in human results on both the 14F and 18F systems.
MANTA closes femoral arterial punctures made during cardiac catheterization procedures such as transcatheter aortic valve replacement (TAVR), balloon aortic valvuloplasty (BAV), and the endovascular treatment of abdominal aortic aneurysms (AAA). These procedures are one of the fastest growing segments of interventional cardiology and closing these punctures without complications is an unmet clinical need. MANTA utilizes novel closure mechanics and can be deployed simply in less than 60 seconds. The potential worldwide market for vascular closure products is approximately $1 billion.
Large bore femoral access and closure has been associated with significant morbidity including bleeding complications, the need for transfusions, increased hospital costs, patient discomfort and disability. The MANTA device has the potential to address all of the shortcomings of current closure methods in one easy to use device. "This conference allows the company additional exposure to the venture community, and should help us to find the right fit for our financing needs," commented Greg Walters, CEO. "We have an exciting technology and look forward to this opportunity to present."
Study reveals AI's potential and pitfalls in medical diagnosis